#MicrobiomeForum

12th Microbiome & Probiotics R&D and Business Collaboration Forum

The 2024 US Microbiome Forum covers gut health and disease, as well as the stunning advances being made in understanding the gut-brain axis. Speakers will report on the developments in Probiotics, Prebiotics, and Postbiotic research as well as personalized nutrition and cardiometabolic disease. There is expanded coverage of Women’s health and, advances in HMO & infant health,  Don’t forget we will explore the challenges and opportunities in translating research towards commercialization, as well as learn how partnerships and collaborations can secure investment.

I am delighted to confirm that Paul Carlson, Principal Investigator, Laboratory of Mucosal Pathogens and Cellular Immunology, CBER, FDA will be speaking about the regulatory considerations for microbiome-based therapeutics.

We will be running our very popular “flash” oral presentations on the Start-ups and Pioneers Stage. If you are a start-up email maria@globalengage.co.uk or complete this form for special bespoke packages designed to make your experience at the meeting exceptional.

The meeting is collocated with the Skin Microbiome & Cosmeceuticals Congress: USA. Go to our resource center for slides and presentations of previous meetings.

Join our LinkedIn Group


Open Letter: Craig R. Cohen, MD, MPH
Professor, Department of Obstetrics, Gynaecology & Reproductive Sciences, University of California, San Francisco.

I am pleased to support the upcoming Microbiome R&D and Business Collaboration Congress in San Diego this October.

Advances in the last few years have provided a much deeper understanding of the complex and dynamic microbial communities that inhabit our bodies and impact our health. High-throughput sequencing and bioinformatics have facilitated more detailed and accurate analyses of microbial communities, revolutionizing our approach to microbiome research. We now know that the microbiome affects everything from mucosal and systemic immune function to mental health and chronic diseases.

Research has led to the creation of targeted live biotherapeutic products to optimize the vaginal microbiome to improve reproductive health outcomes. Yet completing the development process to receive FDA approval has proved challenging. However, clinical trials are taking place and are showing promise for the treatment of bacterial vaginosis and the prevention of preterm birth. In addition, clinical trials of live biotherapeutics have demonstrated efficacy to treat IBS, a range of skin conditions and improve infant health.

I’ll be giving the opening keynote on the potential of live biotherapeutic products to improve vaginal health. Bacterial vaginosis is a common issue with high recurrence rates, but a live biotherapeutic, Lactobacillus crispatus (LACTIN-V), is showing promise in reducing BV and inflammation associated with HIV susceptibility.

The advances are exciting, but we must continue studying these treatments to ensure long-term benefits. I look forward to our discussions at the congress on how we can accelerate the advancement of live biotherapeutics to improve reproductive health!

Best regards,
Craig R. Cohen, MD, MPH

80+ Speakers

7 ½ hours networking time

Vibrant Exhibition Hall

Why Attend

01

Attracting over 250 people the congress is designed to create a collaborative environment in which you can engage with the speakers, sponsors, and other delegations in attendance.

02

Learn how microbiome studies have since shed new light on Parkinson's Disease and how maternal bacterial metabolites may be important neurodevelopmental agents

03

Explore if the manipulation of skin microbial communities, including the use of pre- and probiotics, can maintain skin health and the Potential of LBPs to optimize the vaginal microbiome to improve reproductive health

Confirmed Speakers

Haydeh Payami

Haydeh Payami

Professor of Neurology and Genomics, Strain Endowed Chair in Parkinson’s Disease, University of Alabama at Birmingham

Craig R. Cohen

Craig R. Cohen

Professor, Department of Obstetrics, Guynecology & Reproductive Sciences, University of California San Francisco

Amber Teufel

Amber Teufel

Global Baby, Feminine, and Family Care R&D Group Head/Microbiologist, Proctor & Gamble

David A. Mills

David A. Mills

Distinguished Professor, Peter J. Shields Endowed Chair in Dairy Food Science, Department of Food Science and Technology, University of California-Davis Women

Se Jin Song

Se Jin Song

Director of Research Programs, Center for Microbiome Innovation, UC San Diego

Noah Zimmerman

Noah Zimmerman

Chief Technology Officer, Verb Biotics

Feranmi Aboderin

Feranmi Aboderin

Scientist I, Arcaea

Kera Nyemb-Diop

Kera Nyemb-Diop

Lead Nutritionist, Fonterra

Denise Kelly

Denise Kelly

Investment Advisor, Seventure Partners

Cheri Ackerman

Cheri Ackerman

Co-Founder & CEO, Concerto Biosciences

Lada Rasochova

Lada Rasochova

CEO, Dermala

Natalise Kalea Robinson

Natalise Kalea Robinson

CEO of Parallel Health

James Morton

James Morton

Consultant, Simons Foundation

Nicole Scott

Nicole Scott

CEO & Founder, Cybele

Amy Smith

Amy Smith

Global Regulatory Strategy Lead, Health Dietary Supplement, IFF

Cristina Llorente

Cristina Llorente

Assistant Professor, Div. Gastroenterology, Dept. Medicine, UC San Diego

Jason Bush

Jason Bush

Chief Scientific Officer, Solnul

Josh Parris

Josh Parris

Senior Scientist, Life Sciences, Kimberly Clark Corporation

Eric Chun-Ming Huang

Eric Chun-Ming Huang

Chief Scientific Advisor, Yunneng Biotechnology Co., Ltd.

Ping Hu

Ping Hu

R&D Director Principal Scientist, Procter & Gamble Company, Corporate Function R&D, Discovery & Innovation Platform

Angela M Christiano

Angela M Christiano

Professor of Dermatology and Genetics & Development, Columbia University

Zac Lewis

Zac Lewis

Principal, Lewpine Consulting

Pedro J. Torres

Pedro J. Torres

Principal Scientist, Computational Biology and Data Science, Persephone Biosciences

Cheryl Sew Hoy

Cheryl Sew Hoy

CEO & Founder, Tiny Health

Julia Durack

Julia Durack

VP of R&PD, Symbiome; Director, Holobiont Medical Research Foundation

Tiina Orasmäe-Meder

Tiina Orasmäe-Meder

CEO and founder, Meder by Dr Tiina Meder

Bradley Ringeisen

Bradley Ringeisen

Executive Director, Innovative Genomics Institute (IGI)

Brent Ridge

Brent Ridge

Co-Founder, Beekman1802

Jessica O’Connell

Jessica O’Connell

Partner, Covington & Burling LLP

Amanda L. Lewis

Amanda L. Lewis

Professor, Obstetrics, Gynecology, and Reproductive Sciences, UCSD

Andrea Nardelli

Andrea Nardelli

Post-Doctoral Fellow McMaster University- Farncombe Family Digestive Health Research Institute

Bharat Dixit

Bharat Dixit

Chief Technology Officer, Adiso Therapeutics

Braden Tierney

Braden Tierney

Instructor, Weill Cornell Medical College /Harvard Medical School

Cassandra Isley

Cassandra Isley

Chief Executive Officer, Microbiome Alliance for Disease Prevention

Cecile Vernochet

Cecile Vernochet

Discovery Project Lead, Gates Medical Research Institute

Jun Sun

Jun Sun

Professor/Associate Head, Department of Medicine, University of Illinois Chicago

Krystal Thomas-White

Krystal Thomas-White

Senior Scientist Evvy

Noelle Patno

Noelle Patno

Chief Scientific Officer, Bened Life

Ryan Garrett

Ryan Garrett

Head of Process Development, Vedanta Biosciences

Xin Zhou

Xin Zhou

Postdoctoral Fellow, Snyder Lab, Stanford

Kimberley Sukhum

Kimberley Sukhum

Head of Science, Tiny Health

Alan Murray

Alan Murray

Chairman, Lactalogics

Sathya Janardhanan

Sathya Janardhanan

VP, Manufacturing, Rise Therapeutics

Aubrey Levitt

Aubrey Levitt

CEO, Postbiotics Plus Research LLC

Laura Sycuro

Laura Sycuro

Associate Professor, University of Calgary

Mark Haupt

Mark Haupt

Chief Medical Officer, IFF

Alexandra Castillo-Ruiz

Alexandra Castillo-Ruiz

Assistant Professor, Michigan State University

Ren-Hau Lai

Ren-Hau Lai

Director of Innovation and Product Development, Athletic Greens

Leila Strikland

Leila Strikland

CEO & Co-Founder, BIOMILQ

Laurie Rey

Laurie Rey

Head of CDMO Business Development, Lallemand

default

Alex Sakatos

Co-Founder & CEO, Ancilia Biosciences

Hana Janebdar

Hana Janebdar

Co-Founder & CEO, Juno Bio

Carlotta Ronda

Carlotta Ronda

Principal Investigator, Innovative Genomics Institute at UC Berkeley

Stephanie Fraley

Stephanie Fraley

Associate Professor Shu Chien-Gene Lay Dept of Bioengineering, UCSD

Malcolm Kendall

Malcolm Kendall

Co-Founder & CEO, Microbiome Insights, Inc., Canada

Paul Carlson

Paul Carlson

Elsa Jungman

Elsa Jungman

Founder & CEO, HelloBiome

Agenda Overview

Date Room 1 Room 2 Room 3 Room 4
Day 1 - 17th October
Gut Health & Disease
Gut-Brain Axis
Infant Health, HMO & Nutrition
Skin Microbiome & cosmeceuticals
Day 2 - 18th October
Investment, Regulation and Manufacture
Urology and Women’s Health
Probiotics, Personalised Nutrition, & Cardiometabolic Diseases
Skin Microbiome & Cosmeceuticals

sign up & stay informed


    Sponsors

    Platinum, Gold, Silver and Bronze
    Exhibitor & Content Sponsors

    Venue

    San Diego Marriott La Jolla
    4240 La Jolla Village Dr, La Jolla, CA 92037

    La Jolla hotel’s location is perfect, in San Diego’s Golden Triangle. The hotel offers convenient access to the University of California at San Diego, Scripps Research Institute and La Jolla Shores.

    Our Commitment To Sustainability

    Global Engage is committed to hosting sustainable meetings.

    Event App

    We have reduced waste by replacing printed documentation with an app. Make sure you have it downloaded to your devices in time for the meeting.

    Catering

    You will have some great food choices while you are with us but now, we have worked with the caterer to increase the proportion of plant-based items. We have also built a plan with the venue to avoid waste through how they serve meals and how leftovers are processed.

    Travel

    An international meeting does involve travel but where it is practical, please consider more sustainable alternatives to flying. The app will also have a discussion space to arrange ride shares.

    Poster Presentation and Flash Talks

    Whether looking for funding, employment opportunities or simply wanting to share your work with a like-minded and focused group, presenting a poster is an excellent way to join the heart of this meeting.

    Poster presentations are actively encouraged at this event and as such registered academic, industry, and start-up delegates are invited to present 1 poster each for free.

    The agenda offers two sessions for multiple participants to deliver a Flash Oral Presentation of their posters. This platform is designed to amplify your research, providing a unique opportunity to present your findings to a dedicated audience of industry and academic leaders.

    Submission deadline September 27.

    Download the poster abstract submission form.

     

    Book Your Places

    • Standard Fee

      You Pay:
      $1,299.00 $1,169.10
      Save 10% Before July 31st 31 st Jul 2024
      No Multibuy Discounts
         
         
         
      X

      How many would you like?

      Add To Basket
    • Academic NFP

      You Pay:
      $499.00 $449.10
      Save 10% Before July 31st 31 st Jul 2024
      Multibuy Discounts available
      Buy 3 places pay: $332.66
      Buy 5 places pay: $299.40
      X

      How many would you like?

      Add To Basket
    • Solution Provider Attendee

      You Pay:
      $1,899.00
      No Multibuy Discounts
         
         
         
      X

      How many would you like?

      Add To Basket

    Meet Your Next Big Client – Sponsor An Event

    Sponsor a Global Engage meeting to access senior professionals in the life science industry and build your brand. Our events offer extensive networking opportunities, workshops, speaking positions, one-to-one delegate meetings, and exhibition booths to showcase your products and services. Gain a competitive advantage and position your company as a thought leader. Call us at UK +44 (0)1865 849841 Malaysia +603 2779 0098 to learn more.

    img